Sophie Vacher

29PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsWater treatment processesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.

Abderaouf Hamza, Pierre Gestraud, Maryam Karimi

|Jun 12, 2025
Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature.

Solenn Barraud, Sophie Vacher, Camille Schiffler

|Aug 29, 2024
High Expression of AhR and Environmental Pollution as AhR-Linked Ligands Impact on Oncogenic Signaling Pathways in Western Patients with Gastric Cancer-A Pilot Study.

Martine Perrot-Applanat, Cynthia Pimpie, Sophie Vacher

|May 24, 2024
PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells.

Karina D Rysenkova, Julia Gaboriaud, Artem I Fokin

|Dec 07, 2023
Inactivating negative regulators of cortical branched actin enhances persistence of single cell migration.

Artem I Fokin, Arthur Boutillon, John James

|Jul 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.

Rania El-Botty, Ludivine Morriset, Elodie Montaudon

Pageof 5

Frequent Collaborators

7 joint publications

Ivan Bieche

4 joint publications

Anne Vincent-Salomon

3 joint publications

Thibaut Larcher

3 joint publications

Sandrine M Caputo